Traded Nov 16, 2026 · largest single transaction ~$1.47M
Show all 2 transactions
Nov 16, 202613K
DetailsOfficial recordNov 16, 202624K · @ $61.36
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ABBV · NYSE · Pharmaceuticals
AbbVie (ABBV) · oqro.io/stocks/ABBV · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$286.01−6.81 (−2.33%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Including 89 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Traded Nov 16, 2026 · largest single transaction ~$1.47M
Nov 16, 202613K
DetailsOfficial recordNov 16, 202624K · @ $61.36
DetailsOfficial recordInsider filing
Traded Nov 16 · filed 2 days later
Routine share withholding; mechanical by default.
Azita Saleki-Gerhardt (Officer) plans to sell ~$4.02M of AbbVie
Planned, from payInsider selling
Their largest sale since 2020Traded Nov 9 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −2.5% · S&P 500 −3.0% · to Nov 18
Traded Nov 9, 2026 · largest single transaction ~$2.3M
Nov 9, 202625K
DetailsOfficial recordInsider filing
Traded Nov 12 · filed the same day
Gift or transfer — classified separately from trades.
Jeffrey R Stewart (Officer) plans to sell ~$11.9M of AbbVie
Planned, from payInsider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider selling
Their largest sale since 2023Traded Aug 14 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade +14.7% · S&P 500 −5.9% · to Nov 18
AbbVie's CHIEF BUS/STRAT OFFICER sold $8.18M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 14, 2026 · largest single transaction ~$2.58M
Aug 14, 202633K · @ $79.02
DetailsOfficial recordNicholas Donoghoe (Officer) plans to sell ~$8.18M of AbbVie
Planned, from payInsider filing
Traded Jun 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 8 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 27 · filed 12 days later
Routine share withholding; mechanical by default.
Insider selling
Traded Mar 4 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +21.1% · S&P 500 +6.6% · to Nov 18
AbbVie's SVP, Controller sold $1.22M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Feb 27 · filed 7 days later
Routine share withholding; mechanical by default.
Traded Mar 2, 2026 · largest single transaction ~$2.41MNot reported under a pre-arranged trading plan
Mar 2, 2026~$2.41M · 10K sh @ $234.66
DetailsInsider filing
Traded Feb 27 · filed 4 days later
Routine share withholding; mechanical by default.
Nov 9, 202616K · @ $114.36
Nov 9, 202625K · @ $93.50
DetailsOfficial recordNov 9, 202616K
DetailsOfficial recordAug 14, 202633K
Mar 2, 2026~$1.35M · 5,777 sh @ $233.51
DetailsOfficial recordMar 2, 2026~$612K · 2,600 sh @ $235.26
DetailsOfficial record0 open-market purchases and 2 open-market sales by insiders of ABBV between Jun 6, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 30, 2026. The data provider lists the next release for Feb 2, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Oct 30, 2026 | None | None | 1 sale |
| Oct 5, 2026 | None | None | None |
| Jul 31, 2026 | None | None | 1 sale |
| Jul 6, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies